Injecting Change and Convenience: Pioneering The Future of HIV/AIDS Care in Africa with Long-Acting Antiretrovirals
Dear Editor, We write to bring to attention, a critical matter in public health and infectious diseases research - the advent, implementation, and utilization of Long-ActingAntiretroviralTherapy(LA-ART)injectables, specifically Cabotegravir–Rilpivirine (CAB/RPV), in the context of Africa and the developing regions of the world by extension.
Authors
- Patrick Tobechi Ashinze (ORCID: https://orcid.org/0009-0007-9137-5498)
- Sikiru Ademola Aremu (ORCID: https://orcid.org/0009-0002-5610-4266)
- Emmanuel Egbunu (ORCID: https://orcid.org/0009-0002-4459-9900)
- Nelson Mafua
- Mercy Abiodun-Oludoyi
- Joyce Onyinyechukwu Ndubuisi
- Chigozie Romanus Onwuasoeze
- Deborah Aboyeji
Institutions
- Chukwuemeka Odumegwu Ojukwu University (NG)
- University of Ilorin (NG)
- Lagos University Teaching Hospital (NG)
- Federal Medical Centre (NG)
- Madonna University (NG)
- Lagos State Health Service Commission (NG)
Publication Details
- Journal
- Medical Journal of Zambia
- Published
- 2025-02-03
- DOI
- https://doi.org/10.55320/mjz.52.1.625
- Primary Topic
- HIV/AIDS Impact and Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00